RMD - Vera upgraded at Raymond James on atacicept nephropathy data
2024-01-26 13:17:16 ET
More on Vera Therapeutics
- Vera Therapeutics: Soaring On IgAN Data, But Full Approval A Distant Prospect
- Vera hits 52-week high after long-term data for lead asset (update)
- Vera gains as Jefferies upgrades to Buy on lead asset
- Seeking Alpha’s Quant Rating on Vera Therapeutics
- Historical earnings data for Vera Therapeutics